Back
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
71
EVAV
Direxion Dl Elctrc&Atnms vhcls Bull2XETF
Last Price:
22.50
Seasonality Move:
-28.38%
Sell
40
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
55.63
Seasonality Move:
7.49%
Buy
71
Direxion Dl Elctrc&Atnms vhcls Bull2XETF (EVAV)
is a Buy
Is Direxion Dl Elctrc&Atnms vhcls Bull2XETF a Buy, Sell or Hold?
- The current Direxion Dl Elctrc&Atnms vhcls Bull2XETF [EVAV] share price is $23.30. The Score for EVAV is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- EVAV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $57.74. The Score for BIB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVAV Stock Price Chart
What is Direxion Dl Elctrc&Atnms vhcls Bull2XETF's stock price today?
-
The Direxion Dl Elctrc&Atnms vhcls Bull2XETF share price today is $23.30
The current trend is moderately bullish and EVAV is experiencing slight buying pressure.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $57.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight selling pressure.
EVAV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 59.53 | Buy |
| Chaikin Money Flow: | 1126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.37 - 22.33) | Buy |
| Bollinger Bands (100): | (15.85 - 20.97) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 43.75 | Sell |
| Chaikin Money Flow: | -2006 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.38 - 62.88) | Sell |
| Bollinger Bands (100): | (59.39 - 66.51) | Sell |
EVAV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.28 | Buy |
| 20-day SMA: | 20.47 | Buy |
| 50-day SMA: | 20.07 | Buy |
| 200-day SMA: | 18.92 | Buy |
| 8-day EMA: | 22.54 | Buy |
| 20-day EMA: | 21.21 | Buy |
| 50-day EMA: | 20.02 | Buy |
| 200-day EMA: | 23.31 | Sell |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.55 | Sell |
| 20-day SMA: | 57.6 | Buy |
| 50-day SMA: | 60.91 | Sell |
| 200-day SMA: | 59.96 | Sell |
| 8-day EMA: | 58.37 | Sell |
| 20-day EMA: | 58.81 | Sell |
| 50-day EMA: | 60.41 | Sell |
| 200-day EMA: | 59.98 | Sell |
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Earnings Growth & EVAV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||